Pharma.AI

Insilico Medicine Advances AI-Designed IBD Drug ISM5411 to ‘First-in-Human’ Trial
Featured News Report Technology
Insilico Medicine Advances AI-Designed IBD Drug ISM5411 to ‘First-in-Human’ Trial
December 7, 2023
Hot Stories
Join Our Newsletter.
Latest News